Financhill
Back

Acasti Pharma Quote, Financials, Valuation and Earnings

Acasti Pharma Price Quote

$2.91
-0.01 (-2.02%)
(Updated: June 29, 2024 at 5:50 AM ET)

Acasti Pharma Key Stats

Buy
53
Acasti Pharma (ACST) is a Buy

Day range:
$2.22 - $3.06
52-week range:
$1.72 - $3.84
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.44%

Volume:
86.3K
Avg. volume:
15.3K
1-year change:
-7.3%
Market cap:
$27.4M
Revenue:
$0
EPS:
$-1

How Much Does Acasti Pharma Make?

Data Unavailable

Is Acasti Pharma Growing As A Company?

Data Unavailable

Acasti Pharma Stock Price Performance

  • Did Acasti Pharma Stock Go Up Last Month?
    Acasti Pharma share price went up by 11.03% last month
  • Did ACST's Share Price Rise Over The Last Year?
    ACST share price fell by -7.3% over the past 1 year

What Is Acasti Pharma 52-Week High & Low?

Acasti Pharma Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Acasti Pharma?

  • How Much Debt Does Acasti Pharma Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Acasti Pharma Have?
    Cash and short term investments quarterly total is $23M
  • What Is Acasti Pharma’s Book Value Per Share?
    Book value per share is 6.57

Is Acasti Pharma Cash Flow Positive?

  • What Is ACST Cash Flow From Operations?
    Cash flow from operations (TTM) is -$12.3M
  • What Is Acasti Pharma’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $7.4M
  • What Is Acasti Pharma’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $104K

Acasti Pharma Return On Invested Capital

Data Unavailable

Acasti Pharma Earnings Date & Stock Price

Acasti Pharma Competitors

  • Who Are Acasti Pharma's Competitors?
    Below is a list of companies who compete with Acasti Pharma or are related in some way:
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • ESSA Pharma Inc (EPIX)
    • Lexaria Bioscience Corp (LEXX)
    • Xenon Pharmaceuticals Inc (XENE)

Acasti Pharma Dividend Yield

Data Unavailable

Acasti Pharma Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 25.39%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.00
Upside from Last Price: 105.45%

Major Shareholders

  • How many ACST shares are owned by institutional investors?
    1.8M ACST shares are owned by institutional investors
  • How many ACST shares are owned by insiders?
    780.7K ACST shares are owned by insiders